Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Roche describes new Toll-like receptor 7/8/9 antagonists

Dec. 20, 2019

European Commission approves Rinvoq for rheumatoid arthritis

Dec. 19, 2019

Cantargia announces start of CAN-10 development project for systemic sclerosis and myocarditis

Dec. 10, 2019

Biogen reports phase II data from LILAC study of BIIB-059

Dec. 4, 2019

Impaired ATM function linked to worse rheumatoid arthritis

Dec. 4, 2019

Subcutaneous infliximab biosimilar approved in the E.U. for the treatment of RA

Nov. 28, 2019

Lipids and lupus

Nov. 27, 2019

Upadacitinib demonstrates promising safety and efficacy in phase II/III SELECT-AXIS 1 study

Nov. 25, 2019

Osteoclast precursor macrophages are potential RA therapeutic targets

Nov. 22, 2019

AbbVie constructs anti-TNF-alpha antibody-steroid antibody-drug conjugate for rheumatoid arthritis

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...